| Zeit | Aktuelle Nachrichten
| | Leser | Medien |
|---|
| 10.02.
| Jury Rules Against Mylan In Sunovion Pharma Patent Litigation | | 210 | AFX News |
| CANONSBURG (dpa-AFX) - Mylan Inc. (MYL) announced Friday that a jury has
rendered an unfavorable verdict in a patent infringement lawsuit filed by
Sunovion Pharmaceuticals Inc., f/k/a Sepracor...
Mehr lesen zu:
Jury Rules Against Mylan In Sunovion Pharma Patent Litigation | |
| 10.02.
| Mylan Intends to Challenge Unfavorable Verdict in Patent Trial Related to Mylan's Generic Version of Sunovion's Xopenex® Inhalation Solution | | 144 | PR Newswire |
| PITTSBURGH, Feb. 10, 2012 /PRNewswire/ --Mylan Inc. (Nasdaq: MYL) today announced that a jury has rendered an unfavorable verdict in a patent infringement lawsuit filed by Sunovion...
Mehr lesen zu:
Mylan Intends to Challenge Unfavorable Verdict in Patent Trial Related to Mylan's Generic Version of Sunovion's Xopenex® Inhalation Solution | |
| 10.02.
| Mylan Doxycycline Hyclate tablets win FDA ANDA approval | | 1 | Pharma Bus Review |
| 09.02.
| Mylan says FDA approves generic version of Doryx | | - | Yahoo-USA |
| 09.02.
| Mylan CEO Heather Bresch Testifies Before Congress in Support of Generic Drug User Fee Program and Urges Update of Federal Food, Drug and Cosmetic Act of 1938 to Create a Level Playing Field for Manufacturers | | 61 | PR Newswire |
| PITTSBURGH, Feb. 9, 2012 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) CEO Heather Bresch today testified before the U.S. House of Representatives Energy and Commerce Committee at a hearing hosted by the...
Mehr lesen zu:
Mylan CEO Heather Bresch Testifies Before Congress in Support of Generic Drug User Fee Program and Urges Update of Federal Food, Drug and Cosmetic Act of 1938 to Create a Level Playing Field for Manufacturers | |
| 09.02.
| The Zacks Analyst Blog Highlights: Western Union, Mylan, Valeant Pharmaceuticals, Sanofi and Pfizer | | 33 | PR Newswire |
| CHICAGO, Feb. 9, 2012 /PRNewswire/ -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events...
Mehr lesen zu:
The Zacks Analyst Blog Highlights: Western Union, Mylan, Valeant Pharmaceuticals, Sanofi and Pfizer | |
| 09.02.
| Mylan Unit Secures Final FDA Nod For First Generic Version Of Doryx Tablets | | 28 | AFX News |
| CANONSBURG (dpa-AFX) - Mylan Inc. (MYL) announced that its subsidiary Mylan
Pharmaceuticals Inc. obtained final approval from the U.S. Food and Drug
Administration, or FDA, for its Abbreviated...
Mehr lesen zu:
Mylan Unit Secures Final FDA Nod For First Generic Version Of Doryx Tablets | |
| 09.02.
| UPDATE 1-Mylan beats Impax in generic antibiotic race | | - | Reuters.com |
| 09.02.
| Mylan (MYL) Gets FDA Approval for Generic Doryx | | - | StreetInsider.com |
| 09.02.
| Mylan Receives Final FDA Approval for First Generic Version of Doryx® Tablets, 150 mg | | 18 | PR Newswire |
| PITTSBURGH, Feb. 9, 2012 /PRNewswire/ --Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food...
Mehr lesen zu:
Mylan Receives Final FDA Approval for First Generic Version of Doryx® Tablets, 150 mg | |
| 08.02.
| Mylan Acquires Two Generics | | 2 | Zacks |
| 08.02.
| Mylan purchases two dermatological products from Valeant | | 1 | Pharma Bus Review |
| 07.02.
| Mylan Breaks Through Resistance at $22.43 | | 1 | SmarTrend |
| 06.02.
| Valeant Completes Divestiture Of Generic Dermatology Products To Mylan | | 35 | AFX News |
| CANONSBURG (dpa-AFX) - Valeant Pharmaceuticals International, Inc. (VRX,
VRX.TO) on Monday said it has completed the divestiture of 1 percent clindamycin
and 5 percent benzoyl peroxide gel...
Mehr lesen zu:
Valeant Completes Divestiture Of Generic Dermatology Products To Mylan | |
| 06.02.
| Valeant Pharmaceuticals Completes Divestiture of Generic Dermatology Products to Mylan | | 9 | PR Newswire |
| MISSISSAUGA, Ontario, Feb. 6, 2012 /PRNewswire/ --Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced that it has completed the divestiture of1% clindamycin and 5%...
Mehr lesen zu:
Valeant Pharmaceuticals Completes Divestiture of Generic Dermatology Products to Mylan | |
| 06.02.
| Mylan Completes Acquisition of Two Limited-Competition Dermatological Products from Valeant | | 10 | PR Newswire |
| PITTSBURGH, Feb. 6, 2012 /PRNewswire/ --Mylan Inc. (Nasdaq: MYL) today announced that it has successfully completed the acquisition of two dermatological products from Valeant...
Mehr lesen zu:
Mylan Completes Acquisition of Two Limited-Competition Dermatological Products from Valeant | |
| 03.02.
| MYLAN - In den Starlöchern für 15 % Rally | | 4 | GodmodeTrader.de |
| 03.02.
| Mylan gets tentative FDA nod for generic Lipitor | | 2 | Pharma Bus Review |
| 02.02.
| Mylan Gets Tentative FDA Approval For Generic Version Of Lipitor | | 36 | AFX News |
| CANONSBURG (dpa-AFX) - Mylan Inc. (MYL) said its subsidiary Mylan
Laboratories Ltd. received tentative approval from the U.S. Food and Drug
Administration, or FDA, for its Abbreviated New...
Mehr lesen zu:
Mylan Gets Tentative FDA Approval For Generic Version Of Lipitor | |
| 02.02.
| Mylan (MYL) Unit Gets Tentative FDA Approval for Generic Lipitor Tabs (PFE) | | - | StreetInsider.com |
